FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 3rd, 2023 • Xencor Inc • Pharmaceutical preparations • New York
This First Amendment to the Collaboration and License Agreement (the “First Amendment”) is entered into as of January 30, 2023 (the “First Amendment Effective Date”) by and between Xencor, Inc., a Delaware corporation (“Xencor”), on the one hand, and Janssen Biotech, Inc., a Pennsylvania company (“Janssen”), on the other hand. Xencor and Janssen are referred to herein each individually as a “Party” and collectively as the “Parties.”
